Molecular hydrogen application in stroke: Bench to bedside

Lei Huang; Cameron Lenahan; Warren Boling; Jiping Tang; John H. Zhang

doi:10.2174/1381612826666200917152316

Molecular hydrogen application in stroke: Bench to bedside

Lei Huang, Cameron Lenahan, Warren Boling, Jiping Tang, John H. Zhang

Research output: Contribution to journal › Review article › peer-review

Abstract

Stroke is a major cause of mortality and morbidity worldwide. Effective treatments are limited. Molecular hydrogen is emerging as a novel medical gas with therapeutic potential for various neurological dis-eases, including stroke. We reviewed the experimental and clinical findings of the effects of molecular hydrogen therapy in stroke patients and models. The underlying neuroprotective mechanisms against stroke pathology were also discussed.

Original language	English
Pages (from-to)	703-712
Number of pages	10
Journal	Current Pharmaceutical Design
Volume	27
Issue number	5
DOIs	https://doi.org/10.2174/1381612826666200917152316
State	Published - May 2021

ASJC Scopus Subject Areas

Pharmacology
Drug Discovery

Keywords

Antioxidant
Hydrogen gas
Hydrogen-rich saline
Hydrogen-rich water
Intracerebral hemorrhage
Ischemic stroke
Neuroprotection
Subarachnoid hemorrhage
Neuroprotective Agents/therapeutic use
Hydrogen
Humans
Treatment Outcome
Stroke/drug therapy

Access to Document

10.2174/1381612826666200917152316License: Unspecified

OpenUrl availability

Full text

Cite this

@article{693d3484b989490ba604f95f578774cd,

title = "Molecular hydrogen application in stroke: Bench to bedside",

abstract = "Stroke is a major cause of mortality and morbidity worldwide. Effective treatments are limited. Molecular hydrogen is emerging as a novel medical gas with therapeutic potential for various neurological dis-eases, including stroke. We reviewed the experimental and clinical findings of the effects of molecular hydrogen therapy in stroke patients and models. The underlying neuroprotective mechanisms against stroke pathology were also discussed.",

keywords = "Antioxidant, Hydrogen gas, Hydrogen-rich saline, Hydrogen-rich water, Intracerebral hemorrhage, Ischemic stroke, Neuroprotection, Subarachnoid hemorrhage, Neuroprotective Agents/therapeutic use, Hydrogen, Humans, Treatment Outcome, Stroke/drug therapy",

author = "Lei Huang and Cameron Lenahan and Warren Boling and Jiping Tang and Zhang, {John H.}",

note = "Publisher Copyright: {\textcopyright} 2021 Bentham Science Publishers.",

year = "2021",

month = may,

doi = "10.2174/1381612826666200917152316",

language = "English",

volume = "27",

pages = "703--712",

journal = "Current Pharmaceutical Design",

issn = "1381-6128",

number = "5",

}

TY - JOUR

T1 - Molecular hydrogen application in stroke

T2 - Bench to bedside

AU - Huang, Lei

AU - Lenahan, Cameron

AU - Boling, Warren

AU - Tang, Jiping

AU - Zhang, John H.

PY - 2021/5

Y1 - 2021/5

N2 - Stroke is a major cause of mortality and morbidity worldwide. Effective treatments are limited. Molecular hydrogen is emerging as a novel medical gas with therapeutic potential for various neurological dis-eases, including stroke. We reviewed the experimental and clinical findings of the effects of molecular hydrogen therapy in stroke patients and models. The underlying neuroprotective mechanisms against stroke pathology were also discussed.

AB - Stroke is a major cause of mortality and morbidity worldwide. Effective treatments are limited. Molecular hydrogen is emerging as a novel medical gas with therapeutic potential for various neurological dis-eases, including stroke. We reviewed the experimental and clinical findings of the effects of molecular hydrogen therapy in stroke patients and models. The underlying neuroprotective mechanisms against stroke pathology were also discussed.

KW - Antioxidant

KW - Hydrogen gas

KW - Hydrogen-rich saline

KW - Hydrogen-rich water

KW - Intracerebral hemorrhage

KW - Ischemic stroke

KW - Neuroprotection

KW - Subarachnoid hemorrhage

KW - Neuroprotective Agents/therapeutic use

KW - Hydrogen

KW - Humans

KW - Treatment Outcome

KW - Stroke/drug therapy

UR - http://www.scopus.com/inward/record.url?scp=85100711857&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85100711857&partnerID=8YFLogxK

UR - https://www.mendeley.com/catalogue/4ee72738-4aa4-3c7e-b660-a03a93c09ffc/

U2 - 10.2174/1381612826666200917152316

DO - 10.2174/1381612826666200917152316

M3 - Review article

C2 - 32940172

SN - 1381-6128

VL - 27

SP - 703

EP - 712

JO - Current Pharmaceutical Design

JF - Current Pharmaceutical Design

IS - 5

ER -

Molecular hydrogen application in stroke: Bench to bedside

Abstract

ASJC Scopus Subject Areas

Keywords

Access to Document

OpenUrl availability

Other files and links

Cite this